Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59
Recalled May 1, 2024 · FDA recall D-0466-2024 · Second Tokushima Factory, Otsuka Pharmaceutical
Hazard
Cross Contamination with Other Products · FDA Class III
Units
108,192/30 count bottles or 7 count blister packs
Sold at
USA nationwide.
Description
Cross Contamination with Other Products
Product
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
Manufacturer(s)
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Made in
Japan
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →